prof. dr hab. Piotr Popik

prof. dr hab. Piotr Popik

+48 12 6623375
pokój 30
Zakład Badań Nowych Leków

Dokonania naukowe

  • Publikacje

A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats.

Autorzy: Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, Langer T, Höger H, Golebiowska J, Popik P, Lubec G

DOI: 10.3389/fnbeh.2017.00222
Date: 2017-11-01

Antidepressant-like activity of venlafaxine and clonidine in mice exposed to single prolonged stress - A model of post-traumatic stress disorder. Pharmacodynamic and molecular docking studies.

Autorzy: Malikowska N, Fijałkowski Ł, Nowaczyk A, Popik P, Sałat K

DOI: 10.1016/j.brainres.2017.08.001
Date: 2017-08-01

Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.

Autorzy: Potasiewicz A, Nikiforuk A, Hołuj M, Popik P

DOI: 10.1177/0269881116675509
Date: 2016-11-01

3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.

Autorzy: Potasiewicz A, Hołuj M, Kos T, Popik P, Arias HR, Nikiforuk A

DOI: 10.1016/j.neuropharm.2016.10.002
Date: 2016-10-01

The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors.

Autorzy: Nikiforuk A, Potasiewicz A, Kos T, Popik P

DOI: 10.1016/j.bbr.2016.07.023
Date: 2016-07-01

Trait "pessimism" is associated with increased sensitivity to negative feedback in rats.

Autorzy: Rygula R, Popik P

DOI: 10.3758/s13415-016-0410-y
Date: 2016-06-01

The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors.

Autorzy: Nikiforuk A, Potasiewicz A, Rafa D, Drescher K, Bespalov A, Popik P

DOI: 10.1097/fbp.0000000000000201
Date: 2016-06-01

Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.

Autorzy: Grychowska K, Satała G, Kos T, Partyka A, Colacino E, Chaumont-Dubel S, Bantreil X, Wesołowska A, Pawłowski M, Martinez J, Marin P, Subra G, Zajdel P

DOI: 10.1021/acschemneuro.6b00090
Date: 2016-05-01

Anandamide mediates cognitive judgement bias in rats

Autorzy: Kregiel, J., Malek, N., Popik, P., Starowicz, K., Rygula, R.

DOI: 10.1016/J.NEUROPHARM.2015.09.009
Date: 2016-01-01

The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.

Autorzy: Nikiforuk A, Hołuj M, Kos T, Popik P

DOI: 10.1016/j.neuropharm.2016.01.035
Date: 2016-01-01

Zobacz także